Cargando…
We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?
Autores principales: | Kersten, Daniel J., Makaryus, Amgad N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398429/ https://www.ncbi.nlm.nih.gov/pubmed/32760874 http://dx.doi.org/10.1089/heq.2020.0019 |
Ejemplares similares
-
Ventricular Arrhythmias in Hypertrophic Cardiomyopathy- Can We Ever Predict Them?
por: Namboodiri, Narayanan, et al.
Publicado: (2010) -
A physiologist observing and reporting supra-pharmacologic dobutamine stress testing: can we trust them, and can we trust the results?
por: Porter, Thomas R
Publicado: (2018) -
Biomarkers in community-acquired pneumonia: can we do better by using them correctly?
por: Ranzani, Otavio Tavares, et al.
Publicado: (2019) -
The Conditions of Health: Can We Secure Them ?
Publicado: (1924) -
Facing the COVID-19 emergency: we can and we do
por: Giovagnoni, Andrea
Publicado: (2020)